May 5, 2014
Moving out of RegMed equities is NOT a GOOD long term strategy
May 1, 2014
Aastrom (ASTM) Departure of Directors and Officers - The lifeboats are being lowered, SELL
May 1, 2014
Lower open expected; RegMed’s fear is sentiment on parade
April 29, 2014
RegMed confidence lacks conviction
April 29, 2014
Bristol-Myers Squibb (BMW) acquires iPierian
April 24, 2014
RegMed, another day of “take ‘em down
April 24, 2014
Higher open expected; RegMed cries weekly bubble
April 21, 2014
The Boston Marathon starts here - Hopkinton, Ma!
April 17, 2014
RegMed’s soft but, has a lighter mood
April 10, 2014
Organovo (ONVO) Not effective but, may enable assessments of drug response UP in pre-market +3.92% - SELL on news
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.